Abstract:Cancer is a global health challenge, and early detection is crucial for effective treatment to improve patient outcomes. In recent years, nanomaterial-based biosensors have emerged as powerful tools for the detection of cancer biomarkers in human fluids. This article highlights the recent progress in biosensor technology for the detection of cancer biomarkers, focusing on advancements in sensitivity, selectivity, multiplexed detection, liquid biopsies, point-of-care testing, wearable biosensors, and integration with artificial intelligence (AI). Recent advancements have significantly improved the sensitivity and selectivity of biosensors, allowing for the detection of low concentrations of cancer biomarkers in complex biological samples. Novel sensing technologies, such as nanomaterial-based sensors and aptamer-based sensors, have played a crucial role in enhancing biosensor performance. Multiplexed biosensors have the ability to simultaneously detect multiple cancer biomarkers, providing comprehensive diagnostic information. This capability is particularly valuable for accurate cancer diagnosis and prognosis. Liquid biopsies, which involve the detection of cancer biomarkers in circulating tumor cells, cell-free DNA, or exosomes present in body fluids, have gained considerable attention. Biosensors have played a pivotal role in the development of liquid biopsy technologies, offering non-invasive and real-time monitoring of cancer progression, treatment response, and the emergence of drug resistance. Integration of biosensors with AI algorithms has shown great potential. AI can analyze and interpret biosensor data, identifying patterns, correlations, and biomarker signatures that may be difficult to detect with traditional methods.

Nanomaterial-based Microfluidic Systems for Cancer Biomarker Detection: Recent Applications and Future Perspectives

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Recent Progress on Nanomaterial‐Facilitated Electrochemical Strategies for Cancer Diagnosis

Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles

Nanotechnology-Assisted Isolation and Analysis of Circulating Tumor Cells on Microfluidic Devices

Nanomaterial based analytical methods for breast cancer biomarker detection

Leveraging Nanomaterials for Ultrasensitive Biosensors in Early Cancer Detection: A Review

Magnetic nanotechnology for circulating tumor biomarkers screening: Rational design, microfluidics integration and applications

Application of Metal-Based Nanomaterials in In Vitro Diagnosis of Tumor Markers: Summary and Prospect

Recent Progress of Biomarker Detection Sensors

Nanomaterial-assisted microfluidics for multiplex assays

Microfluidics-Based Urine Biopsy for Cancer Diagnosis: Recent Advances and Future Trends

Microfluidics and Nanomaterial-based Technologies for Circulating Tumor Cell Isolation and Detection

Recent advances in nanomaterials for prostate cancer detection and diagnosis

Recent progress in Nanomaterial based biosensors for the detection of cancer biomarkers in human fluids

Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy

Optical nanomaterial-based detection of biomarkers in liquid biopsy

Nanomaterial-Mediated Immunosensors and Their Performance in Detecting Tumor Markers

Recent advances in nanomaterials for colorimetric cancer detection

Recent advances in droplet‐based microfluidics in liquid biopsy for cancer diagnosis

Nanomaterial-Based Immunocapture Platforms for the Recognition, Isolation, and Detection of Circulating Tumor Cells